AIM ImmunoTech Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
29.0M
on 2026-06-30, from 503K on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-100 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
$3.4M
Agreement of 2026-04-10. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗
Cash
2.8 quarters
$10.0M on 2026-06-30 ÷ $3.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-06-09 | Public offering | 2,554,119 | $0.5189 | $1.3M | 424B5 ↗ |
| 2026-05-20 | Public offering with warrants at $0.33 | 7,519,351 | $0.325 | $2.4M | 424B5 ↗ |
| 2026-05-19 | Public offering | not read | not read | not read | 424B5 ↗ |
| 2026-02-10 | Public offering | not read | not read | not read | 424B4 ↗ |
| 2025-07-28 | Public offering | not read | $4.00 | $8.0M | 424B5 ↗ |